New cancer vaccine seeks to train immune system to fight advanced tumors
NCT ID NCT04041310
Summary
This study is testing a new genetic vaccine, called Nous-209, given alongside the immunotherapy drug pembrolizumab (Keytruda®). The goal is to see if this combination is safe and can help control advanced cancers that have a specific genetic feature (MSI-H or dMMR), including colorectal, stomach, and gastro-esophageal junction tumors. The trial is for adults whose cancer cannot be removed by surgery or has spread, and it aims to see if the vaccine can boost the body's immune response against the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR, ADULT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AOUS Policlinico Le Scotte
Siena, 53100, Italy
-
Aorn Sg Moscati
Avellino, 83100, Italy
-
Boca Raton Clinical Research
Plantation, Florida, 33322, United States
-
CHU de Liège
Liège, 4000, Belgium
-
Candiolo cancer Center,FPO IRCCS
Candiolo, 10060, Italy
-
Centre Hospitalier de l'Ardenne - Libramont - Clinique du Sein
Libramont, 6800, Belgium
-
City of Hope Comprehensive Cancer Center
Duarte, California, 91010, United States
-
City of Hope Comprehensive Cancer Center
Irvine, California, 92618, United States
-
Clinica Universidad de Navarra
Madrid, 28027, Spain
-
Clinica Universidad de Navarra
Pamplona, 31008, Spain
-
Cliniques Universitaires Saint-Luc - Centre du Cancer
Brussels, 1200, Belgium
-
Complejo Asistencial de Salamanca
Salamanca, 37007, Spain
-
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, 20133, Italy
-
Goshen Center for Cancer Care
Goshen, Indiana, 46526, United States
-
Hospital Clinic de Barcelona
Barcelona, Spain
-
Hospital Clínico Universitario de Santiago de Compostela
Santiago de Compostela, 15706, Spain
-
Hospital Del Mar
Barcelona, 08003, Spain
-
Hospital General Universitario Gregorio Marañón
Madrid, 28007, Spain
-
Hospital General Universitario de Valencia
Valencia, 46014, Spain
-
Hospital Universitari Dexeus
Barcelona, 08028, Spain
-
Hospital Universitario 12 de Octubre
Madrid, 28041, Spain
-
Hospital Universitario Fundación Jiménez Díaz
Madrid, 28040, Spain
-
Hospital Universitario HM Sanchinarro
Madrid, Spain
-
Hospital Universitario La Paz
Madrid, 28046, Spain
-
Hospital Universitario Marques de Valdecilla
Santander, Spain
-
Hospital Universitario Miguel Servet
Zaragoza, 50009, Spain
-
Hospital Universitario Reina Sofia
Córdoba, 14004, Spain
-
Hospital Universitario Virgen de las Nieves
Granada, 18014, Spain
-
Hospital Universitario de A Coruna
A Coruña, 15006, Spain
-
Hospital Vall d'Hebron
Barcelona, 08035, Spain
-
IRCCS Ospedale San Raffaele
Milan, 20132, Italy
-
Institut Catala d'Oncologia Hospitalet
Barcelona, 08908, Spain
-
Johns Hopkins University
Baltimore, Maryland, 21287, United States
-
MD Anderson Cancer Center (MDACC)
Houston, Texas, 77030, United States
-
Mount Sinai Hospital
Toronto, M5G 2M9, Canada
-
Mt. Sinai
Miami Beach, Florida, 33140, United States
-
NYU Langone Medical Center
New York, New York, 10016, United States
-
Ospedale Niguarda
Milan, 20162, Italy
-
Princess Margaret Cancer Center
Toronto, M5G 2M9, Canada
-
Roswell Park Comprehensive Cancer Center
Buffalo, New York, 14203, United States
-
USC Norris Comprehensive Cancer Center
Los Angeles, California, 90089, United States
-
USC Norris Comprehensive Cancer Center
Newport Beach, California, 92663, United States
-
University Clinical Hospital Valencia
Valencia, Spain
-
University College London Hospitals NHS Foundation Trust Cancer Clinical Trials Unit
London, United Kingdom
-
Washington University School of Medicine, Division of Oncology
St Louis, Missouri, 63110, United States
-
Weill Cornell Medicine / New York-Presbyterian Hospital
New York, New York, 10021, United States
Conditions
Explore the condition pages connected to this study.